Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
INBODY CO.,LTD |
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 24,450.00 KRW | -0.20% | +1.88% | +21.04% | |
| May. 15 | InBody Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2022 | InBody Releases BPBIO 220 and BPBIO 250 | CI |
| Sales 2023 * | 172 0 | Sales 2024 * | 200 0 | Capitalization | 319 B 246 M |
|---|---|---|---|---|---|
| Net income 2023 * | 36 0 | Net income 2024 * | 42 0 | EV / Sales 2023 * | 1,23x |
| Net cash position 2023 * | 107 0 | Net cash position 2024 * | 122 0 | EV / Sales 2024 * | 0,98x |
| P/E ratio 2023 * | 9,28x | P/E ratio 2024 * | 7,81x | Employees | 275 |
| Yield 2023 * | 1,36% | Yield 2024 * | 1,84% | Free-Float | 66.50% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.20% | ||
| 1 week | +2.30% | ||
| Current month | -0.20% | ||
| 1 month | +13.46% | ||
| 3 months | -6.68% | ||
| 6 months | -8.43% | ||
| Current year | +21.04% |
1 week
23 550.00
24 650.00
1 month
21 400.0025 750.00
Current year
19 250.0032 550.00
1 year
18 250.0032 550.00
3 years
16 550.0032 850.00
5 years
13 350.0032 850.00
10 years
7 290.0059 600.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ra-Mi Lee
CEO | Chief Executive Officer | 47 | - |
Ki-Chul Cha
FOU | Founder | 65 | 1996 |
Woo-Seong Bang
BRD | Director/Board Member | 44 | 2019 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Young-Pil Park
BRD | Director/Board Member | 75 | - |
Ki-Chul Cha
FOU | Founder | 65 | 1996 |
Chang-Heon Woo
BRD | Director/Board Member | 56 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.20% | 56 M€ | 0.00% | - | |
| 0.03% | 589 M€ | +3.30% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-01 | 24,450.00 | -0.20% | 23,857 |
| 23-11-30 | 24,500.00 | +1.45% | 21,580 |
| 23-11-29 | 24,150.00 | +1.26% | 16,832 |
| 23-11-28 | 23,850.00 | +0.42% | 11,292 |
| 23-11-27 | 23,750.00 | -1.04% | 14,672 |
End-of-day quote Korea Stock Exchange, December 30, 2023
More quotes
InBody Co., Ltd., formerly Biospace Co., Ltd., is a Korea-based company engaged in the manufacture of electronic medical devices. The Company mainly produces body composition analyzers under the brand names of InBody and LookinâBody. The Company mainly produces body composition analyzers under the brand name InBody and LookinâBody. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include LookinâBody3.0 and LookinâBody Basic, which are used for measuring proteins, minerals, fats, moistures and others. It also provides body mass index (BMI) measuring devices under the brand name of BSM. The Company distributes its products within domestic market and to overseas markets.
Calendar
2024-03-31
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
24,450.00KRW
Average target price
37,500.00KRW
Spread / Average Target
+53.37%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +21.04% | 246 M $ | |
| -9.91% | 192 B $ | |
| -15.80% | 165 B $ | |
| +18.83% | 109 B $ | |
| +21.33% | 81 878 M $ | |
| +13.76% | 64 423 M $ | |
| -8.19% | 49 296 M $ | |
| -8.38% | 41 066 M $ | |
| -13.94% | 37 333 M $ | |
| +18.89% | 31 166 M $ |
